EVALUATION OF HEPATIC DENSITY CHANGE BY DYNAMIC CT IN HEALTHY HUMANS AND IN PATIENTS WITH CHRONIC LIVER-DISEASES

被引:3
|
作者
SUGANO, S [1 ]
OKAJIMA, T [1 ]
KUBO, S [1 ]
YAMAZAKI, Y [1 ]
SUMINO, Y [1 ]
ABEI, T [1 ]
机构
[1] TOHO UNIV,SCH MED,DEPT MED,TOKYO 143,JAPAN
关键词
DYNAMIC COMPUTED TOMOGRAPHY; CHRONIC VIRAL HEPATITIS; POSTHEPATITIC LIVER CIRRHOSIS; ALCOHOLIC LIVER CIRRHOSIS;
D O I
10.1007/BF01308175
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Dynamic computed tomography using 0.4 ml/kg of 65% meglumine diatrizoate was performed to estimate pharmacokinetics of contrast media in the liver in healthy controls (N = 11), in patients with chronic viral hepatitis (N = 17), posthepatitic liver cirrhosis (N = 21), and alcoholic liver cirrhosis (N = 23). The time of peak enhancement (the time interval between peak aortic and liver enhancement) was significantly different between each group. Alcoholic liver cirrhosis was the most prolonged, followed by posthepatitic liver cirrhosis, chronic viral hepatitis, and finally controls. A peak enhancement time of 28 sec had a diagnostic accuracy of 97% for chronic liver diseases. A time greater than 44 sec had a diagnostic accuracy for cirrhosis of 96%. The decay time (the time from peak enhancement of the liver to the curve's center of gravity) was also significantly different between each group. Again, alcoholic liver cirrhosis was the longest, followed by posthepatitic liver cirrhosis, chronic viral hepatitis, and then the controls. Dynamic computed tomography has many potential applications in studying intrahepatic physiologic events and may contain diagnostic information for chronic liver diseases.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 50 条
  • [31] NITRIC-OXIDE PRODUCTION IN PATIENTS WITH CHRONIC LIVER-DISEASES
    HORI, N
    TAKAHASHI, H
    OKANOUE, T
    MORI, T
    SAKAMOTO, S
    NANBU, A
    YOSHIMURA, M
    KASHIMA, K
    HEPATOLOGY, 1993, 18 (04) : A101 - A101
  • [32] PERITONEOSCOPY, NEEDLE-LIVER BIOPSY AND HEPATIC SCINTIGRAPHY - DIAGNOSTIC VALUE IN CHRONIC LIVER-DISEASES
    VANTINI, I
    ANGELINI, G
    CAVALLIN.G
    MIRACHIA.R
    DOBRILLA, G
    RENDICONTI DI GASTRO-ENTEROLOGIA, 1973, 5 (01): : 57 - 57
  • [33] RIBONUCLEASE-ACTIVITIES IN LIVER-TISSUE OF PATIENTS WITH CHRONIC LIVER-DISEASES
    TSUJI, H
    MURAI, K
    AKAGI, K
    FUJISHIMA, M
    CLINICA CHIMICA ACTA, 1990, 191 (1-2) : 101 - 104
  • [34] DEVELOPMENT AND ACTIVITY OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC-ALCOHOLIC LIVER-DISEASES
    POTT, G
    VOSS, B
    HOGEMANN, B
    RAUTERBERG, J
    GERLACH, U
    HEPATOLOGY, 1982, 2 (01) : 184 - 184
  • [35] EVALUATION OF CELLULAR IMMUNITY IN CHRONIC LIVER-DISEASES DURING IMMUNOSUPPRESSIVE TREATMENT
    SALERNO, F
    TORNAGHI, G
    CAPPELLI.MD
    FARGION, S
    FIORELLI, G
    BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE, 1974, 53 (01): : 272 - 272
  • [36] COMPUTER SCINTIGRAPHY STUDY OF HEPATIC BLOOD-FLOW IN CHRONIC DIFFUSE LIVER-DISEASES
    PODYMOVA, SD
    FRENKEL, VE
    ALEKSEEVA, TE
    BUDANOV, SV
    GOVOROVA, OA
    KLINICHESKAYA MEDITSINA, 1988, 66 (08): : 102 - 105
  • [37] EFFECTS OF ENZYME-INDUCING COMPOUNDS ON HEPATIC FUNCTION AND DRUG-METABOLISM IN PATIENTS WITH CHRONIC LIVER-DISEASES
    SOTANIEMI, EA
    PELKONEN, RO
    RAUTIO, A
    JARVENSIVU, PM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 25 (02) : 250 - 250
  • [38] HISTOCHEMICAL STUDIES OF HEPATIC HEXOKINASE AND GLUCOSE 6-PHOSPHATASE IN CHRONIC LIVER-DISEASES
    AOE, H
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1975, 8 (02) : 120 - 133
  • [39] ENDOTOXEMIA IN A SERIES OF 104 PATIENTS WITH CHRONIC LIVER-DISEASES - PREVALENCE AND SIGNIFICANCE
    GAETA, GB
    PERNA, P
    ADINOLFI, LE
    UTILI, R
    RUGGIERO, G
    DIGESTION, 1982, 23 (04) : 239 - 244
  • [40] FUNCTIONAL-ACTIVITY OF NATURAL KILLERS IN PATIENTS WITH CHRONIC LIVER-DISEASES
    DZHALALOVA, VA
    MADZHIDOV, AV
    DROZD, TN
    POGROMOV, AP
    TERAPEVTICHESKII ARKHIV, 1985, 57 (02) : 74 - 77